share_log

Matinas Biopharma Announces Complete Clinical Resolution Of A Patient's Recurrent Hemorrhagic Cystitis Due To Candida Krusei, A Fluconazole Inherited Resistant Fungal Pathogen, Following Treatment With MAT2203

Benzinga ·  Oct 11, 2023 07:40
Matinas Biopharma Announces Complete Clinical Resolution Of A Patient's Recurrent Hemorrhagic Cystitis Due To Candida Krusei, A Fluconazole Inherited Resistant Fungal Pathogen, Following Treatment With MAT2203
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment